STVN Stevanato: Earnings per share for the last 12 months

Stevanato Group S.p.A. maintains a duopoly in the premium glass packaging segment, benefiting from the demand for GLP-1 drugs. The GURU.Markets interface displays this chart, where the annual EPS TTM growth rate has reached 4.90, reflecting current profit levels. The company generates revenue from the production of vials and syringes, yet faces pressure from declining customer inventories and energy prices.
Financial and market metric breakdowns for Stevanato Group Corp (STVN)

This indicator measures the rate of change in net earnings per share over a rolling year, allowing for a real-time assessment of business resilience to market shocks. By analyzing the annual EPS (TTM) change, an investor determines the stability of returns for Stevanato Group S.p.A. amid volatile vaccine demand and inflationary pressure on the cost of specialized glass raw materials.